Invivyd, Inc.
IVVD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001832038
In the last 90 days, Invivyd, Inc. insiders filed 0 open-market purchases and 5 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $203.1M in total; Maverick Capital is the only superinvestor holding it.
Q4 2021 vs. Q3 2021
How the institutions holding Invivyd, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 67 | 1 | 80 | +14 |
| Shares | 52.2M | 42.6K | 60.0M | +7.84M (+15.0%) |
| Value | $2.16B | $1.80M | $431.9M | −$1.73B (−80.0%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (35)
Institutions that held Invivyd, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (21)
Institutions that held Invivyd, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Antipodean Advisors LLC | 190,000 | $8.03M |
| Ensign Peak Advisors, Inc | 113,183 | $4.78M |
| Gilder Gagnon Howe & Co LLC | 99,887 | $4.22M |
| Darwin Global Management, Ltd. | 86,528 | $3.65M |
| Caas Capital Management LP | 40,000 | $1.69M |
| Ghisallo Capital Management LLC | 40,000 | $1.69M |
| EAM Investors, LLC | 29,289 | $1.24M |
| Two Sigma Investments, LP | 23,713 | $1.00M |
| Rokos Capital Management LLP | 20,000 | $826.0K |
| Pinz Capital Management, LP | 18,323 | $774.0K |
| Mirabella Financial Services LLP | 16,180 | $683.0K |
| SEI Investments Co | 14,681 | $620.0K |
| Inverness Counsel LLC | 12,000 | $507.0K |
| M&T Bank Corp | 10,320 | $436.0K |
| SG Americas Securities, LLC | 9,500 | $401.0K |
| Voya Investment Management LLC | 8,181 | $346.0K |
| Invesco Ltd. | 7,044 | $298.0K |
| Silverarc Capital Management, LLC | 5,000 | $211.0K |
| Lindbrook Capital, LLC | 800 | $34.0K |
| American Portfolios Advisors | 560 | $23.7K |
| IFP Advisors, Inc | 100 | $4.00K |
Not filed for Q4 2021 yet (1)
Institutions that held Invivyd, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace North America L.P. | 42,640 | $1.80M |